MYO1D and acute myeloid leukemia: Moreover, Mu et al. (2022) reported that SPAG6 was highly expressed in AML and promoted its progression through the epidermal growth factor receptor (EGFR) family in a myosin 1D (MYO1D)-dependent manner.